omeprazole has been researched along with technetium tc 99m sestamibi in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abbaszadeh, M; Assadi, M; Jallalat, S; Javadi, H; Mogharrabi, M; Nabipour, I; Semnani, S; Tabib, SM | 1 |
Qutbi, M | 1 |
2 other study(ies) available for omeprazole and technetium tc 99m sestamibi
Article | Year |
---|---|
The association of increased stomach wall radiotracer uptake with prolonged use of omeprazole capsules on myocardial perfusion imaging (MPI) using 99mTc-sestamibi SPECT.
Topics: Artifacts; Biological Transport; Capsules; Female; Gastric Mucosa; Humans; Middle Aged; Myocardial Perfusion Imaging; Omeprazole; Radioactive Tracers; Stomach; Technetium Tc 99m Sestamibi; Time Factors; Tomography, Emission-Computed, Single-Photon | 2013 |
What is this image? 2019: ImageĀ 2 result : Reduction in interfering gastric wall uptake on myocardial perfusion SPECT following a 2-week period of omeprazole withdrawal.
Topics: Female; Heart Ventricles; Humans; Middle Aged; Myocardial Perfusion Imaging; Omeprazole; Proton Pump Inhibitors; Stomach; Substance Withdrawal Syndrome; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |